Experts in identifying and obtaining worldwide cancer treatment solutions for metastatic cancer patients

Yours, Nir Erez, CEO, TRIAL•IN Pharma

Because we do not give up on life and increase the chances of cancer patients for survival and longevity

Cancer Types:

  • Bladder Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • DIPG – Brain Stem Cancer
  • Gastric Cancer
  • Glioblastoma
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Skin Cancer And Melanoma
  • Thyroid Cancer

The scope of our patient support

  • We carry out procedures that allow us to find breakthrough and cutting-edge treatment methods worldwide for specific patients and their clinical conditions.

  • These actions are conducted by experienced oncologists who analyze extensive medical information to provide a list of additional targeted treatment options for the specific patient.

  • Our oncologist recommends and collaborates with the patient to choose the treatment that offers the best chances.

  • We continuously accompany the patient and provide professional support at all stages of the treatment process.

Who is our support intended for?

  • All patients with stage 4 metastatic cancer: metastatic breast cancer, metastatic lung cancer, metastatic colorectal cancer, metastatic ovarian cancer, or any other type of secondary tumor.
  • All patients with stage 4 brain tumors, such as glioblastoma.
  • Note: This study is not intended for patients with various stages of leukemia or hematologic patients.

Who we are in contact with:

  • With leading scientists and research teams at top oncology centers worldwide
  • Pharmaceutical companies globally
  • We translate medical documents
  • We maintain direct contact with the patient’s oncologist to report and provide guidance on the treatment process
  • We assist in completing necessary paperwork and sending forms to various relevant partners, including strict monitoring to ensure that the right person receives the documents, processes them, and forwards them for treatment implementation
  • We minimize the time in which the patient receives treatment. All of this is carried out with professional assistance from our team.

When do you need our support?

  • Before starting the first treatment when the disease is diagnosed as metastatic or when a brain tumor is diagnosed.
  • In cases of disease progression for metastatic cancer or brain tumors.
  • Advanced personalized therapies have been identified for all cancer patients who have contacted us.
  • We maintain continuous contact with patients, providing advice, guidance, management, and assistance in all aspects of their complex daily care throughout the treatment process.
  • Patients with stage 3b or stage 4 metastatic cancer of any type, such as breast cancer with metastases, lung cancer with metastases, colorectal cancer with metastases, ovarian cancer with metastases, or any other metastatic cancer.
  • All patients with stage 4 brain tumors, such as Glioblastoma (GBM).
  • Patients with aggressive cancers without metastases, such as pancreatic cancer, stomach cancer, triple-negative breast cancer, and others.
  • Note: Our service is NOT intended for various types of blood cancers or hematologic patients.

Patient coordination and support process

1. How is the process conducted?

Our team of oncologists and clinical researchers employs a unique working method developed by our team, which involves gathering extensive information on research and advanced treatment methods tailored individually to the situation and disease of each specific patient according to their clinical condition.

Our oncologists meticulously review over 100 databases as well as medical literature across the spectrum of cancer diseases. This process takes from two to three weeks.


2. What does the detailed report contain?

  • A list of worldwide clinical trials with innovative medications deemed suitable for the patient and meeting criteria.
  • Palliative medications worldwide that are appropriate for the patient.
  • Case studies detailing the administration of specific medications to similar patients with impressive therapeutic success.
  • Professional literature and publications supporting some or all of the described treatment methods.
    Information on other innovative treatment methods, such as advanced radiology, which the team believes may enhance treatment success.
  • Breakthrough medications available in Israel or abroad for treatment at the medical center where the patient is being treated, eliminating the need for travel abroad to participate in a study.
  • Links to detailed information on each procedure and locations where they can be obtained.

3. What else does the patient receive?

After receiving the report, our team discusses the findings in detail with the patient and their family based on the written report. It is important for us that the patient and their family fully understand the test results and are actively involved in choosing the treatment. Once the most appropriate treatment protocol is selected from the list according to the oncologist’s recommendations, we provide counseling and closely accompany the patient to implement this treatment in practice.


4. How is the treatment chosen?

During the patient’s next visit to their oncologist at the medical center, they discuss all options to select the best treatment protocol tailored to the patient’s disease characteristics. With the report, the oncologist now has the information and necessary details to recommend treatments that go beyond standard protocols.

The patient’s oncologist plays a decisive role in treatment selection because they know the patient better than anyone else. Therefore, the report and results should not be viewed as treatment recommendations but rather as personalized information on treatment methods to consider alongside the usual standard treatments for that particular patient.

A new era in medicine.

Cutting-edge global therapies at your fingertips.